Galapagos NV
GLPG
#4535
Rank
โ‚ฌ1.84 B
Marketcap
27,65ย โ‚ฌ
Share price
2.21%
Change (1 day)
7.04%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -0,28ย โ‚ฌ

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -0,29ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of 1,00ย โ‚ฌ a decrease over its 2023 EPS that were of 3,04ย โ‚ฌ.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,28ย โ‚ฌ-128.09%
20241,00ย โ‚ฌ-67.16%
20233,04ย โ‚ฌ-199.64%
2022-3,05ย โ‚ฌ99.03%
2021-1,53ย โ‚ฌ-68.98%
2020-4,93ย โ‚ฌ-298.06%
20192,49ย โ‚ฌ-554.64%
2018-0,55ย โ‚ฌ-77.18%
2017-2,40ย โ‚ฌ-326.21%
20161,06ย โ‚ฌ-134.19%
2015-3,10ย โ‚ฌ-371.34%
20141,14ย โ‚ฌ-445.98%
2013-0,33ย โ‚ฌ32.88%
2012-0,25ย โ‚ฌ-82.07%
2011-1,39ย โ‚ฌ-817.9%
20100,19ย โ‚ฌ12.73%
20090,17ย โ‚ฌ-120.79%
2008-0,83ย โ‚ฌ-37.67%
2007-1,32ย โ‚ฌ39.64%
2006-0,95ย โ‚ฌ28.17%
2005-0,74ย โ‚ฌ6.25%
2004-0,70ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
2,60ย โ‚ฌ-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
8,93ย โ‚ฌ-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
3,17ย โ‚ฌ-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
1,16ย โ‚ฌ-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-1,26ย โ‚ฌ 333.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
6,89ย โ‚ฌ-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0,54ย โ‚ฌ-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
3,08ย โ‚ฌ-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
6,49ย โ‚ฌ-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA